StockData
BioStem Technologies, Inc. logo

BioStem Technologies, Inc. (BSEM) SEC filings

BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$0.64−0.07 (-10.23%)

Close on Nov 20, 2026Market cap $11.34MP/E –Yield –

SEC filings

7 of BioStem Technologies's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QSep 30, 2026Nov 12, 2026SEC EDGAR
Current report8-KNov 12, 2026Nov 12, 2026SEC EDGAR
Current report8-KSep 29, 2026Sep 30, 2026SEC EDGAR
Current report8-KSep 18, 2026Sep 18, 2026SEC EDGAR
Current report8-KAug 12, 2026Aug 12, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 12, 2026SEC EDGAR
Current report8-KAug 6, 2026Aug 7, 2026SEC EDGAR

See a number that looks wrong?